The PROSASH incorporated albumin, AFP, AST, creatinine, age, extrahepatic spread, macrovascular invasion, ECOG PS and disease aetiology (nine parameters in total), whereas the PROSASH‐II incorporated albumin, AFP, extrahepatic spread, macrovascular invasion, tumour size and bilirubin (six parameters in total). This evidence concerns the gene ALB and neoplasm.